PowerShares Dynamic Biotechnology & Genome Portfolio ETF (PBE) - NYSEARCA
  • Singles & Doubles | Send Message 11 Aug 2015

    $PTH, $PBE, and PJP remain leaders for aggressive ETF portfolio. http://bit.ly/1HEFwim
      • Vetr | Send Message 14 Apr 2015

        A Retail ETF to Remember $LOW $WAG $CVS $PJP $WMT $COST $PBE $PMR http://bit.ly/1IIGyjd
          • Cliff Smith | Send Message 1 Nov 2014

            ETF Recommendations For November 3, 2014 $PBE, $IYR, $PJP http://seekingalpha.com/p/21a93
              • Vetr | Send Message 5 Sep 2014

                Interesting Biotech ETF Additions on the Way $IBB $XBI $PBE http://bit.ly/1uDkY5F
                  • Vetr | Send Message 25 Aug 2014

                    InterMune Acquisition Could Ignite These Biotech ETFs $FBT $IDIX $ITMN $XBI $MRK $PBE http://bit.ly/1qh2mYV
                      • Vetr | Send Message 24 Jun 2014

                        Vertex Lifts These Biotech ETFs $VRTX $BBH $FBT $MRK $IDIX $XBI $PBE $ICPT http://bit.ly/1jdJSCn
                          • Cliff Smith | Send Message 14 Jun 2014

                            ETF Updates For June 16, 2014 $PBE, $IYR, $RWX http://seekingalpha.com/p/1rkwn
                              • Lior Vider | Send Message 31 Mar 2014

                                Best Investment Options For The Biotechnology Sector $XBI, $PBE http://seekingalpha.com/p/1nzl3
                                  • Cliff Smith | Send Message 28 Feb 2014

                                    Tactical Strategy Recommendations For March 3, 2014 $FPX, $PBE, $GURU http://seekingalpha.com/p/1lsan
                                      • Justin M. Hall | Send Message 20 Dec 2010

                                        PBE's climb may be evidence that Biotech's chipping away at BiG Pharma (hand sitters). Patents expire, Biotech Booms 2011+. To Be Continued.
                                          PBE Description
                                          The PowerShares Dynamic Biotechnology & Genome Portfolio (Fund) is based on the Dynamic Biotechnology & Genome Intellidex Index (Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.
                                          See more details on sponsor's website
                                          Sector: Healthcare
                                          Country: United States
                                          ETF Hub
                                          Find the right ETFs for your portfolio: Visit Seeking Alpha's ETF Hub